Reference health
What If There Was a Stronger Pharmaceutical Price Competition in Spain? When Regulation Has a Similar Effect to Collusion
1 of 42 checkable references need attention · checked 2026-08-28
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
9 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
does not resolve to a known work10.1162/105864097567039
The 41 checked references that resolve
resolves10.1007/s10198-007-0050-9
Economic aspects of the new Spanish laws on pharmaceutical preparations
resolves10.1023/A:1012504310953
The Impact of Generic Drug Competition on Brand Name Market Shares – Evidence from Micro Data
resolves10.1287/mnsc.44.11.1533
Logit Demand Estimation Under Competitive Pricing Behavior: An Equilibrium Framework
resolves10.2307/3087454
Market Segmentation and the Sources of Rents from Innovation: Personal Computers in the Late 1980s
resolves10.1017/s0266466600005727
Variance Components Structures for the Extreme-Value and Logistic Distributions with Application to Models of Heterogeneity
resolves10.1016/s0140-6736(03)13636-7
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
resolves10.1111/1467-6451.00127
The Importance of Doctors’ and Patients’ Preferences in the Prescription Decision
resolves10.1007/s10198-006-0357-y
Price regulation and generic competition in the pharmaceutical market
resolves10.1007/s00181-007-0135-4
GMM estimation of a structural demand model for yogurt and the effects of the introduction of new brands
resolves10.2307/2556023
Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins
resolves10.1086/467257
Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act
resolves10.1172/jci32741
The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity
resolves10.2307/2555818
The Importance of the Physician in the Generic versus Trade-Name Prescription Decision
resolves10.1111/j.0741-6261.2007.00115.x
Experts' agency problems: evidence from the prescription drug market in Japan
resolves10.2139/ssrn.1685213
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark
resolves10.1111/j.1468-0327.2008.00207.x
Competition in off-patent drug markets: Issues, regulation and evidence
resolves10.1185/030079907x219571
Pharmacy discounts on generic medicines in France: is there room for further efficiency savings?
resolves10.2307/2600994
Mergers with Differentiated Products: The Case of the Ready-to-Eat Cereal Industry
resolves10.1111/j.1430-9134.2000.00513.x
A Practitioner's Guide to Estimation of Random‐Coefficients Logit Models of Demand
resolves10.1016/j.healthpol.2007.02.010
The impact of generic reference pricing interventions in the statin market
resolves10.1016/j.healthpol.2010.06.016
Do generic firms and the Spanish public purchaser respond to consumer price differences of generics under reference pricing?
resolves10.1257/jep.7.3.97
Pricing, Profits, and Technological Progress in the Pharmaceutical Industry
resolves10.1016/s0002-9149(03)00004-3
Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals
The 9 references without a DOI — listed, not checked
no DOI — not checkedref3
no DOI — not checkedAnuario de la Competencia
no DOI — not checkedref11
no DOI — not checkedref13
no DOI — not checkedThe pharmaceutical market regulation in Spain: is drug cost-containment under question
no DOI — not checkedref18
no DOI — not checkedEstudio del impacto de los medicamentos gen�ricos en el mercado espa�ol
no DOI — not checkedImpacto de la regulaci�n de precio de los medicamentos sobre la competencia en el mercado de gen�ricos: valoraci�n de los efectos y necesidad de reforma
no DOI — not checkedref48
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-08-28 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.1856872"><img src="https://citestamp.com/citestamped/10.2139/ssrn.1856872/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.1856872)